Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome
- PMID: 32056910
- DOI: 10.1016/j.jad.2020.01.124
Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome
Abstract
Background Anxiety/depression and irritable bowel syndrome (IBS) are highly prevalent and burdensome conditions, whose co-occurrence is estimated between 44 and 84%. Shared gut microbiota alterations have been identified in these separate disorders relative to controls; however, studies have not adequately considered their comorbidity. This review set out to identify case-control studies comparing the gut microbiota in anxiety/depression, IBS, and both conditions comorbidly relative to each other and to controls, as well as gut microbiota investigations including measures of both IBS and anxiety/depression. Methods Four databases were systematically searched using comprehensive search terms (OVID Medline, Embase, PsycINFO, and PubMed), following PRISMA guidelines. Results Systematic review identified 17 studies (10 human, 7 animal). Most studies investigated the gut microbiota and anxiety/depression symptoms in IBS cohorts. Participants with IBS and high anxiety/depression symptoms had lower alpha diversity compared to controls and IBS-only cohorts. Machine learning and beta diversity distinguished between IBS participants with and without anxiety/depression by their gut microbiota. Comorbid IBS and anxiety/depression also had higher abundance of Proteobacteria, Prevotella/Prevotellaceae, Bacteroides and lower Lachnospiraceae relative to controls. Limitations A large number of gut microbiota estimation methods and statistical techniques were utilized; therefore, meta-analysis was not possible. Conclusions Well-designed case-control and longitudinal studies are required to disentangle whether the gut microbiota is predicted as a continuum of gastrointestinal and anxiety/depression symptom severity, or whether reported dysbiosis is unique to IBS and anxiety/depression comorbidity. These findings may inform the development of targeted treatment through the gut microbiota for individuals with both anxiety/depression and IBS.
Keywords: Anxiety; Depression; Gut microbiota; Irritable bowel syndrome; Microbiome; Systematic review.
Copyright © 2020. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest None
Similar articles
-
Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.J Acad Nutr Diet. 2020 Apr;120(4):565-586. doi: 10.1016/j.jand.2019.05.015. Epub 2019 Aug 28. J Acad Nutr Diet. 2020. PMID: 31473156
-
A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome.Psychosom Med. 2018 Oct;80(8):698-709. doi: 10.1097/PSY.0000000000000630. Psychosom Med. 2018. PMID: 30095672 Free PMC article. Clinical Trial.
-
Irritable bowel syndrome and gut microbiota.Curr Opin Endocrinol Diabetes Obes. 2020 Feb;27(1):28-35. doi: 10.1097/MED.0000000000000523. Curr Opin Endocrinol Diabetes Obes. 2020. PMID: 31789724 Review.
-
Depression Promotes the Onset of Irritable Bowel Syndrome through Unique Dysbiosis in Rats.Gut Liver. 2019 May 15;13(3):325-332. doi: 10.5009/gnl18296. Gut Liver. 2019. PMID: 30602220 Free PMC article.
-
Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain.Nutrients. 2021 Aug 31;13(9):3061. doi: 10.3390/nu13093061. Nutrients. 2021. PMID: 34578939 Free PMC article. Review.
Cited by
-
Toward a better understanding of intermittent fasting effects: Ramadan fasting as a model.Am J Clin Nutr. 2021 May 8;113(5):1075-1076. doi: 10.1093/ajcn/nqab017. Am J Clin Nutr. 2021. PMID: 33711099 Free PMC article. No abstract available.
-
Gut dysbiosis induces the development of depression-like behavior through abnormal synapse pruning in microglia-mediated by complement C3.Microbiome. 2024 Feb 20;12(1):34. doi: 10.1186/s40168-024-01756-6. Microbiome. 2024. PMID: 38378622 Free PMC article.
-
Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta-analysis of randomized control trials.Health Sci Rep. 2022 Sep 12;5(5):e814. doi: 10.1002/hsr2.814. eCollection 2022 Sep. Health Sci Rep. 2022. PMID: 36110348 Free PMC article.
-
A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome.BMC Gastroenterol. 2024 Jul 5;24(1):217. doi: 10.1186/s12876-024-03311-x. BMC Gastroenterol. 2024. PMID: 38970007 Free PMC article.
-
Irritable Bowel Syndrome or Psychiatric Disorders: Which Comes First?J Neurogastroenterol Motil. 2022 Jul 30;28(3):335-336. doi: 10.5056/jnm22065. J Neurogastroenterol Motil. 2022. PMID: 35799228 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources